转导管主动脉替换后的-葡萄糖共传输体-2 抑制剂:一个元分析
Hritvik Jain1, Kriti Soni2, Jyoti Jain3
1From the Department of Medicine, All India Institute of Medical Sciences, Jodhpur, India.
Cardiology in review
|December 16, 2025
概括
-葡萄糖共传输体-2 抑制剂 (SGLT2is) 在过导管大动脉置换 (TAVR) 后显著减少心力衰竭住院. 然而,SGLT2is并没有影响TAVR患者的全因或心血管死亡率.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 已知-葡萄糖共传输体-2 抑制剂 (SGLT2is) 可以减少心力衰竭 (HF) 的入院率.
- 有限的数据存在于SGLT2i有效性在接受过导管大动脉置换 (TAVR) 的大动脉狭窄患者.
研究的目的:
- 系统地审查和比较TAVR后SGLT2i和无SGLT2i患者的临床结果.
- 评估SGLT2i对心力衰竭住院和TAVR后死亡率的影响.
主要方法:
- 在2025年4月之前对主要电子数据库进行系统审查和元分析.
- 包括两项研究,1534名TAVR患者 (679名SGLT2i,855名非SGLT2i).
- 使用随机效应模型组合风险比率 (RR),P ≤0.05被认为是显著的.
主要成果:
- 通过SGLT2i治疗显著减少了HF住院时间 (RR:0.56;95%CI:0.32-0.99;P=0.05).
- 没有观察到任何原因死亡率的显著差异 (RR:0.48;95% CI:0.13-1.72;P = 0.26).
- 在心血管死亡率方面没有发现显著差异 (RR:0.53;95% CI:0.19-1.48;P = 0.22).
结论:
- SGLT2 抑制剂与TAVR后心力衰竭住院病例的显著减少有关.
- 在TAVR后,SGLT2抑制剂没有显示出所有原因或心血管死亡率的降低.
- 需要进一步的随机对照试验来指导SGLT2i在TAVR后的使用建议.
更多相关视频
09:57Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
3.1K
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
11.0K
相关概念视频
01:27Glucose Transporters
27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
01:55Secondary Active Transport
136.5K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
136.5K
01:32Secondary Active Transport
9.2K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
9.2K